TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tyrian Diagnostics Limited
Tyrian Diagnostics Completes Feasibility Study for Tuberculosis Diagnostic with Becton, Dickinson & Company
January 20th, 2009
Tyrian Diagnostics Limited (ASX:TDX) announced that the Company has completed Milestone 4 of a feasibility study in collaboration with Becton, Dickinson and Company (BD) to determine the suitability of Tyrian’s proprietary tuberculosis (TB) protein markers for the development of rapid diagnostic tests to detect active TB disease. The feasibility study demonstrated detection of selected proprietary TB proteins in sputum, along with the development of methods for sample preparation and testing suitable for use in the field. Tyrian has identified a lead marker which may be particularly suitable for a diagnostic test because it is an essential TB protein, meaning that it is...
Source: TB & Outbreaks Week (2009-01-20)
|
